Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Thai PainPREDICT for detecting neuropathic pain in people with diabetes

Official title: Thai Version of PainPREDICT: Translation, Validation, and Mobile Application Development for Screening Painful Diabetic Neuropathy in Diabetes Patients

Run by Chulalongkorn University · NCT07195045 · Data updated 2026-11-12

This project will test a Thai-language PainPREDICT questionnaire and a companion mobile app to help identify neuropathic pain in adults with type 1 or type 2 diabetes.

More Neuropathic Pain trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment277 (estimated)
SponsorChulalongkorn University
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Pathum Wan, Bangkok)
StatusRecruiting
StartedAugust 28, 2025
Main results expectedAugust 27, 2027
Study endsDecember 31, 2027
Registry record updatedOctober 3, 2025
Trial IDNCT07195045 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with type 1 or type 2 diabetes who can communicate in Thai and provide informed consent are ideal candidates.

Probably not a fit

People with neuropathy from other known causes, significant cognitive impairment or severe psychiatric illness, or those who cannot use Thai-language tools are unlikely to benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project will translate and culturally adapt the internationally used PainPREDICT questionnaire into Thai, followed by psychometric testing including internal consistency and test-retest reliability. A mobile application embedding the Thai PainPREDICT will be developed and refined through clinician and patient usability testing using the System Usability Scale and qualitative feedback. Finally, diagnostic accuracy and real-world usability will be evaluated in 200–300 adults with diabetes by comparing questionnaire results to clinician diagnosis and objective neurophysiological tests such as nerve conduction studies and quantitative sensory testing. The study is conducted at King Chulalongkorn Memorial Hospital and includes subgroup analyses to gauge performance in resource-limited settings.

Why it matters

Potential benefit: If successful, the Thai PainPREDICT and app could enable earlier, more accessible detection and monitoring of painful diabetic neuropathy and reduce delays to treatment.

How similar studies have gone: The PainPREDICT questionnaire has been validated internationally, but its formal translation, cultural adaptation, and mobile integration for Thai patients are novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years or older.
* Diagnosed with type 1 diabetes mellitus or type 2 diabetes mellitus.
* Able to communicate in Thai.
* Willing and able to provide written informed consent.

Exclusion Criteria:

* Presence of neuropathy due to other causes (e.g., alcohol, chemotherapy, HIV, other systemic diseases).
* Significant cognitive impairment or neurological conditions that prevent comprehension of the questionnaire.
* Severe psychiatric illness that interferes with study participation.

Where it's running

  • King Chulalongkorn Memorial hospital, The Thai Red Cross Society
    Pathum Wan, Bangkok, Thailand
    Recruiting

Study contacts

  • Principal investigator: Jakkrit Amornvit, MD — King Chulalongkorn Memorial Hospital
  • Study coordinator: Jakkrit Amornvit, MD
  • Email: jakkrit.a@chula.ac.th
  • Phone: +66622169338

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.